在喘中,SERPINB10促进了中性呼吸道炎症
Weiqiang Kong1, Chunli Huang2, Lu Zhao2
1Huazhong University of Science and Technology Tongji Medical College Tongji Hospital, Division of Respiratory and Critical Care Medicine, Department of Internal Medicine, Tongji Hospital, Wuhan, China.
American journal of respiratory cell and molecular biology
|October 10, 2025
概括
塞尔宾B10通过通过NF-κB和NLRP3通道增强IL-1β和IL-6的表达,驱动喘中性呼吸道炎症. 这种蛋白质是潜在的治疗喘与呼吸道中性友好症的目标.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
- 分子生物学分子生物学
背景情况:
- 严重的喘可能涉及中性友气道炎症,NLRP3炎症酶途径与上皮细胞激活有关.
- SERPINB10与炎症状况中的中性粒细胞激活有关,这表明它可能在喘病变发生过程中发挥作用.
研究的目的:
- 为了研究SERPINB10在喘中中性友气道炎症中的作用.
- 探索SERPINB10影响呼吸道上皮细胞中的炎症通路的分子机制.
主要方法:
- 使用了一种小鼠喘模型,该模型对室内灰尘虫 (HDM) 敏感,并对HDM和聚I:C提出挑战.
- 在肺组织和支气管支气管洗液中评估中性粒细胞数量,炎症细胞透和细胞因子表达 (IL-1β,IL-6).
- 采用培养的人类支气管上皮细胞 (HBE) 来研究SERPINB10敲击和过度表达对NF-κB和NLRP3炎症体信号传递的影响.
- 从喘患者的支气管刷中分析了SERPINB10表达.
主要成果:
- 与野生类型小鼠相比,缺乏Serpinb10 (Serpinb10-/-) 的小鼠显示中性粒细胞数量减少和呼吸道炎症.
- 缺少SERPINB10会降低IL-1β和IL-6的表达,以及肺中的NLRP3和亲IL-1β水平.
- 在HBE细胞中,SERPINB10 knockdown通过抑制IκBα酸化来抑制聚I:C诱导的IL-1β和IL-6表达.
- 过度表达SERPINB10增强了IL-1β和IL-6的产生,其作用被NF-κB和NLRP3抑制剂阻断.
- 在非酸性喘患者中,SERPINB10表达升高与空气流量限制严重程度和炎症标志物相关联.
结论:
- 通过对NF-κB和NLRP3信号进行上调,SERPINB10促进了气道上皮细胞中IL-1β和IL-6的表达.
- 这些作用有助于中性友气道炎症在喘.
- 喘中SERPINB10代表了一种潜在的治疗点,用于控制喘中的呼吸道中性友好症.
相关概念视频
01:26Asthma-II: Pathophysiology and Classification
4.1K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.1K
01:20Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
01:19Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K
01:29Asthma-I: Introduction
3.4K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.4K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K